These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 12063742)

  • 21. Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's wort ( Hypericum perforatum ).
    Johne A; Schmider J; Brockmöller J; Stadelmann AM; Störmer E; Bauer S; Scholler G; Langheinrich M; Roots I
    J Clin Psychopharmacol; 2002 Feb; 22(1):46-54. PubMed ID: 11799342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential therapy of mild to moderate depressive episodes (ICD-10 F 32.0; F 32.1) with St. John's wort.
    Friede M; Henneicke von Zepelin HH; Freudenstein J
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S38-41. PubMed ID: 11518073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. St John's Wort (Hypericum perforatum)--a herbal antidepressant.
    Hippius H
    Curr Med Res Opin; 1998; 14(3):171-84. PubMed ID: 9787983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
    Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
    Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
    Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
    Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of St. John's wort (Hypericum perforatum) treatment: a 1-year safety study in mild to moderate depression.
    Brattström A
    Phytomedicine; 2009 Apr; 16(4):277-83. PubMed ID: 19299116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypericum perforatum (St John's wort) beyond depression: A therapeutic perspective for pain conditions.
    Galeotti N
    J Ethnopharmacol; 2017 Mar; 200():136-146. PubMed ID: 28216196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. St. John's wort.
    Lawvere S; Mahoney MC
    Am Fam Physician; 2005 Dec; 72(11):2249-54. PubMed ID: 16342849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How effective is St John's wort? The evidence revisited.
    Werneke U; Horn O; Taylor DM
    J Clin Psychiatry; 2004 May; 65(5):611-7. PubMed ID: 15163246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical application of St. John's wort (Hypericum perforatum).
    Wölfle U; Seelinger G; Schempp CM
    Planta Med; 2014 Feb; 80(2-3):109-20. PubMed ID: 24214835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study.
    Kobak KA; Taylor LV; Bystritsky A; Kohlenberg CJ; Greist JH; Tucker P; Warner G; Futterer R; Vapnik T
    Int Clin Psychopharmacol; 2005 Nov; 20(6):299-304. PubMed ID: 16192837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St. John's Wort].
    Röder C; Schaefer M; Leucht S
    Fortschr Neurol Psychiatr; 2004 Jun; 72(6):330-43. PubMed ID: 15211398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of oral administration of extracts of Hypericum perforatum (St John's wort) on brain serotonin transporter, serotonin uptake and behaviour in mice.
    Hirano K; Kato Y; Uchida S; Sugimoto Y; Yamada J; Umegaki K; Yamada S
    J Pharm Pharmacol; 2004 Dec; 56(12):1589-95. PubMed ID: 15563766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. St. John's wort does not interfere with therapeutic drug monitoring of 12 commonly monitored drugs using immunoassays.
    Dasgupta A; Tso G; Szelei-Stevens K
    J Clin Lab Anal; 2006; 20(2):62-7. PubMed ID: 16538644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. St. John's wort (Hypericum perforatum) and breastfeeding: plasma and breast milk concentrations of hyperforin for 5 mothers and 2 infants.
    Klier CM; Schmid-Siegel B; Schäfer MR; Lenz G; Saria A; Lee A; Zernig G
    J Clin Psychiatry; 2006 Feb; 67(2):305-9. PubMed ID: 16566628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. St. John's Wort (Hypericum perforatum): clinical effects on depression and other conditions.
    Miller AL
    Altern Med Rev; 1998 Feb; 3(1):18-26. PubMed ID: 9600023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of hepatocellular toxicity associated with the components of St. John's Wort extract hypericin and hyperforin in HepG2 and HepaRG cells.
    Abegg VF; Panajatovic MV; Mancuso RV; Allard JA; Duthaler U; Odermatt A; Krähenbühl S; Bouitbir J
    Toxicol Lett; 2024 Mar; 393():1-13. PubMed ID: 38219807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. St. John's wort: a new alternative for depression?
    Josey ES; Tackett RL
    Int J Clin Pharmacol Ther; 1999 Mar; 37(3):111-9. PubMed ID: 10190758
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.